Vericel Corp. (VCEL)
38.34
+0.47
(+1.24%)
USD |
NASDAQ |
Sep 11, 16:00
38.33
-0.01
(-0.03%)
After-Hours: 20:00
Vericel Price to Book Value : 5.302 for Sept. 11, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 5.302 |
| September 10, 2026 | 5.237 |
| September 09, 2026 | 5.392 |
| September 08, 2026 | 5.404 |
| September 04, 2026 | 5.558 |
| September 03, 2026 | 5.596 |
| September 02, 2026 | 5.654 |
| September 01, 2026 | 5.600 |
| August 31, 2026 | 5.518 |
| August 28, 2026 | 5.663 |
| August 27, 2026 | 5.695 |
| August 26, 2026 | 5.869 |
| August 25, 2026 | 5.977 |
| August 24, 2026 | 5.849 |
| August 21, 2026 | 5.902 |
| August 20, 2026 | 5.823 |
| August 19, 2026 | 6.025 |
| August 18, 2026 | 6.120 |
| August 17, 2026 | 6.028 |
| August 14, 2026 | 6.112 |
| August 13, 2026 | 6.159 |
| August 12, 2026 | 6.186 |
| August 11, 2026 | 6.133 |
| August 10, 2026 | 6.078 |
| August 07, 2026 | 6.235 |
| Date | Value |
|---|---|
| August 06, 2026 | 6.188 |
| August 05, 2026 | 6.273 |
| August 04, 2026 | 6.408 |
| August 03, 2026 | 6.368 |
| July 31, 2026 | 6.356 |
| July 30, 2026 | 6.584 |
| July 29, 2026 | 6.447 |
| July 28, 2026 | 6.459 |
| July 27, 2026 | 6.267 |
| July 24, 2026 | 6.230 |
| July 23, 2026 | 6.229 |
| July 22, 2026 | 6.162 |
| July 21, 2026 | 6.380 |
| July 20, 2026 | 6.344 |
| July 17, 2026 | 6.450 |
| July 16, 2026 | 6.611 |
| July 15, 2026 | 6.461 |
| July 14, 2026 | 6.374 |
| July 13, 2026 | 6.567 |
| July 10, 2026 | 6.499 |
| July 09, 2026 | 6.680 |
| July 08, 2026 | 6.502 |
| July 07, 2026 | 6.492 |
| July 06, 2026 | 6.438 |
| July 02, 2026 | 6.497 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| AbbVie, Inc. | -- |
| ADMA Biologics, Inc. | 5.096 |
| Kyntra Bio, Inc. | -- |
| Conexeu Sciences, Inc. | 16.58 |
| ACADIA Pharmaceuticals, Inc. | 3.666 |
Price to Book Value Related Metrics
| PE Ratio | 82.93 |
| PS Ratio | 6.480 |
| PEG Ratio | 0.306 |
| Price to Free Cash Flow | 32.19 |
| Price | 38.34 |
| Earnings Yield | 1.21% |
| Market Cap | 1.962B |
| PEGY Ratio | 0.306 |
| Operating PE Ratio | 108.84 |
| Normalized PE Ratio | 82.95 |